Andreas Viardot: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)

Norbert Schmitz, Maike Nickelsen, Marita Ziepert, Mathias Haenel, Peter Borchmann, Christian Schmidt, Andreas Viardot, Martin Bentz, Norma Peter, Gerhard Ehninger, Gottfried Doelken, Christian Ruebe,

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 385 KB

english, 2012

2

PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma

Gopal, Ajay K., Kahl, Brad S., de Vos, Sven, Wagner-Johnston, Nina D., Schuster, Stephen J., Jurczak, Wojciech J., Flinn, Ian W., Flowers, Christopher R., Martin, Peter, Viardot, Andreas, Blum, Kristi

Journal:

New England Journal of Medicine

Year:

2014

Language:

english

File:

PDF, 674 KB

english, 2014

3

Perspektiven der CAR-T-Zell-Therapie; Perspectives on CAR T-cell treatment;

Viardot, Andreas

Journal:

Year:

2020

File:

PDF, 643 KB

2020

4

Single Nucleotide Polymorphisms in IKZF1, ARID5B and CEBPE are a Risk Factor for the Development of Adult ALL

Burmeister, Thomas, Bartels, Gesine, Gröger, Daniela, Trautmann, Heiko, Schwartz, Stefan, Lenz, Klaus, Tietze-Bürger, Carola, Viardot, Andreas, Wäsch, Ralph, Horst, Heinz-August, Reinhardt, Richard, G

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2014

Language:

english

File:

PDF, 75 KB

english, 2014

5

Comparison of minimal residual disease levels in bone marrow and peripheral blood in adult acute lymphoblastic leukemia

Kotrova, Michaela, Volland, Antonia, Kehden, Britta, Trautmann, Heiko, Ritgen, Matthias, Wäsch, Ralph, Faul, Christoph, Viardot, Andreas, Schwartz, Stefan, Baldus, Claudia D., Gökbuget, Nicola, Brügge

Journal:

Year:

2019

File:

PDF, 616 KB

2019

6

Chimeric antigen receptor (CAR) T-cell therapy as a treatment option for patients with B-cell lymphomas: perspectives on the therapeutic potential of Axicabtagene ciloleucel

Viardot, Andreas, Wais, Verena, Sala, Elisa, Koerper, Sixten

Journal:

Cancer Management and Research

Year:

2019

Language:

english

File:

PDF, 313 KB

english, 2019

7

Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

Kroschinsky, Frank, Middeke, Jan Moritz, Janz, Martin, Lenz, Georg, Witzens-Harig, Mathias, Bouabdallah, Reda, La RosÃ©e, Paul, Viardot, Andreas, Salles, Gilles, Kim, Seok Jin, Kim, Tae Min, Ottmann,

Journal:

Investigational New Drugs

Year:

2020

File:

PDF, 159 KB

2020

8

Bispecific antibodies in haematological malignancies

Viardot, Andreas, Bargou, Ralf

Journal:

Cancer Treatment Reviews

Year:

2018

Language:

english

File:

PDF, 1.17 MB

english, 2018

9

Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma

KÃ¶nig, Laila, Herfarth, Klaus, HÃ¶rner-Rieber, Juliane, Dietrich, Sascha, Wiegel, Thomas, Debus, JÃ¼rgen, Viardot, Andreas

Journal:

Strahlentherapie und Onkologie

Year:

2020

File:

PDF, 669 KB

2020

10

Unusual transformation of primary extranodal marginal zone B cell lymphoma of the uterus into a nodal follicular lymphoma grade IIIB

Grunenberg, Alexander, Möller, Peter, Viardot, Andreas, Teleanu, Veronica, Eiermann, Dagmar, Buske, Christian, Barth, Thomas F.

Journal:

Annals of Hematology

Year:

2019

File:

PDF, 790 KB

2019

11

Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B cell non-Hodgkin lymphoma

Kroschinsky, Frank, Middeke, Jan Moritz, Janz, Martin, Lenz, Georg, Witzens-Harig, Mathias, Bouabdallah, Reda, La RosÃ©e, Paul, Viardot, Andreas, Salles, Gilles, Kim, Seok Jin, Kim, Tae Min, Ottmann,

Journal:

Investigational New Drugs

Year:

2020

File:

PDF, 158 KB

2020

12

Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial

König, Laila, Dreyling, Martin, Dürig, Jan, Engelhard, Marianne, Hohloch, Karin, Viardot, Andreas, Witzens-Harig, Mathias, Kieser, Meinhard, Klapper, Wolfram, Pott, Christiane, Herfarth, Klaus

Journal:

Year:

2019

Language:

english

File:

PDF, 932 KB

english, 2019

13

Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma

Viardot, Andreas, Hess, Georg, Bargou, Ralf C., Morley, Nicholas J., Gritti, Giuseppe, Goebeler, Maria-Elisabeth, Iskander, Karim, Cohan, David, Zhang, Alicia, Franklin, Janet, Coyle, Luke

Journal:

Leukemia and Lymphoma

Year:

2020

File:

PDF, 1.07 MB

2020

14

Gain of chromosome arm 9p is characteristic of primary mediastinal b-cell lymphoma (MBL): Comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line

Martin Bentz, Thomas F. E. Barth, Silke Brüderlein, Daliah Bock, Michael J. Schwerer, Michael Baudis, Stefan Joos, Andreas Viardot, Alfred C. Feller, Hans-Konrad Müller-Hermelink, Peter Lichter, Hartm

Journal:

Genes, Chromosomes and Cancer

Year:

2001

Language:

english

File:

PDF, 131 KB

english, 2001

15

Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma

Herfarth, Klaus, Borchmann, Peter, Schnaidt, Sven, Hohloch, Karin, Budach, Volker, Engelhard, Marianne, Viardot, Andreas, Engenhart-Cabillic, Rita, Keller, Ulrich, Reinartz, Gabriele, Eich, Hans-Theod

Journal:

Year:

2018

File:

PDF, 575 KB

2018

16

Value of comparative genomic hybridization and fluorescence in situ hybridization for molecular diagnostics in multiple myeloma

Peter Liebisch, Andreas Viardot, Nicole Baßermann, Christiane Wendl, Katrin Roth, Hartmut Goldschmidt, Hermann Einsele, Christian Straka, Stephan Stilgenbauer, Hartmut Döhner, Martin Bentz

Journal:

British Journal of Haematology

Year:

2003

Language:

english

File:

PDF, 180 KB

english, 2003

17

Management indolenter Lymphome

Viardot, Andreas, Buske, Christian

Journal:

Im Focus Onkologie

Year:

2014

Language:

german

File:

PDF, 382 KB

german, 2014

18

CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B

Magdalena Hagn, Verena Ebel, Kai Sontheimer, Elisabeth Schwesinger, Oleg Lunov, Thamara Beyer, Dorit Fabricius, Thomas F. E. Barth, Andreas Viardot, Stephan Stilgenbauer, Julia Hepp, Karin Scharffette

Journal:

European Journal of Immunology

Year:

2010

Language:

english

File:

PDF, 371 KB

english, 2010

19

Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia

Gökbuget, Nicola, Zugmaier, Gerhard, Klinger, Matthias, Kufer, Peter, Stelljes, Matthias, Viardot, Andreas, Horst, Heinz A., Neumann, Svenja, Brüggemann, Monika, Ottmann, Oliver G., Burmeister, Thomas

Journal:

Year:

2017

Language:

english

File:

PDF, 701 KB

english, 2017

20

Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status

Carsten Schwaenen, Andreas Viardot, Hilmar Berger, Thomas F. E. Barth, Stefan Bentink, Hartmut Döhner, Martina Enz, Alfred C. Feller, Martin-Leo Hansmann, Michael Hummel, Hans A. Kestler, Wolfram Klap

Journal:

Genes, Chromosomes and Cancer

Year:

2009

Language:

english

File:

PDF, 462 KB

english, 2009

21

Cytogenetic evolution of follicular lymphoma

Andreas Viardot, Thomas F.E. Barth, Peter Möller, Hartmut Döhner, Martin Bentz

Journal:

Seminars in Cancer Biology

Year:

2003

Language:

english

File:

PDF, 105 KB

english, 2003

22

Chemoimmunotherapy with ofatumumab in combination with CHOP in previously untreated follicular lymphoma

Myron S. Czuczman, Georg Hess, Ole V. Gadeberg, Lars M. Pedersen, Nancy Goldstein, Ira Gupta, Roxanne C. Jewell, Thomas S. Lin, Steen Lisby, Claus Strange, Kristian Windfeld, Andreas Viardot, for the

Journal:

British Journal of Haematology

Year:

2012

Language:

english

File:

PDF, 177 KB

english, 2012

23

Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

Kroschinsky, Frank, Middeke, Jan Moritz, Janz, Martin, Lenz, Georg, Witzens-Harig, Mathias, Bouabdallah, Reda, La RosÃ©e, Paul, Viardot, Andreas, Salles, Gilles, Kim, Seok Jin, Kim, Tae Min, Ottmann,

Journal:

Investigational New Drugs

Year:

2020

Language:

english

File:

PDF, 449 KB

english, 2020

24

Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study

Salles, Gilles, Schuster, Stephen J., de Vos, Sven, Wagner-Johnston, Nina D., Viardot, Andreas, Blum, Kristie A., Flowers, Christopher R., Jurczak, Wojciech J., Flinn, Ian W., Kahl, Brad S., Martin, P

Journal:

Year:

2017

Language:

english

File:

PDF, 1.60 MB

english, 2017

25

Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia

Kobitzsch, Benjamin, Gökbuget, Nicola, Schwartz, Stefan, Reinhardt, Richard, Brüggemann, Monika, Viardot, Andreas, Wäsch, Ralph, Starck, Michael, Thiel, Eckhard, Hoelzer, Dieter, Burmeister, Thomas

Journal:

Year:

2017

Language:

english

File:

PDF, 1.21 MB

english, 2017

26

Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies

Viardot, Andreas, Locatelli, Franco, Stieglmaier, Julia, Zaman, Faraz, Jabbour, Elias

Journal:

Annals of Hematology

Year:

2020

File:

PDF, 569 KB

2020

27

Chemotherapiefreie Behandlung indolenter Lymphome: Hype oder Hope?; Treatment of indolent lymphoma without chemotherapy: hype or hope?;

Viardot, Andreas, Heß, Georg

Journal:

Year:

2019

Language:

german

File:

PDF, 322 KB

german, 2019

28

Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial

Friedrichs, Birte, Nickelsen, Maike, Ziepert, Marita, Altmann, Bettina, Haenel, Mathias, Viardot, Andreas, Schmidt, Christian, Ruebe, Christian, Loeffler, Markus, Pfreundschuh, Michael, Rosenwald, And

Journal:

British Journal of Haematology

Year:

2018

Language:

english

File:

PDF, 205 KB

english, 2018

29

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

Poeschel, Viola, Held, Gerhard, Ziepert, Marita, Witzens-Harig, Mathias, Holte, Harald, Thurner, Lorenz, Borchmann, Peter, Viardot, Andreas, Soekler, Martin, Keller, Ulrich, Schmidt, Christian, Truemp

Journal:

Lancet (London, England)

Year:

2019

File:

PDF, 479 KB

2019

30

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial

Wulf, Gerald G., Altmann, Bettina, Ziepert, Marita, DâAmore, Francesco, Held, Gerhard, Greil, Richard, Tournilhac, Olivier, Relander, Thomas, Viardot, Andreas, Wilhelm, Martin, Wilhelm, Christian, P

Journal:

Year:

2020

File:

PDF, 904 KB

2020

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски